Top

Published in:

01-07-2018 | Original Article

¹⁸F-FDG-PET/CT: an accurate method to assess the activity of Takayasu’s arteritis

Authors: Xiaojie Zhang, Jun Zhou, Ying Sun, Hongcheng Shi, Zongfei Ji, Lindi Jiang

Published in: Clinical Rheumatology | Issue 7/2018

Abstract

The objective of the study is to investigate the value of ¹⁸F-fluorodeoxyglucose–positron emission tomography/computed tomography (¹⁸F-FDG-PET/CT) for assessment of the activity of Takayasu’s arteritis (TA) and the correlation between acute-phase reactive proteins (ARPs) and standard uptake value (SUV). Analyses of the clinical characteristics and 42 ¹⁸F-FDG-PET/CT scans in 39 TA patients were undertaken. The degree of FDG uptake in the blood vessel walls was assessed quantitatively by SUV. TA activity was analyzed by physician global assessment (PGA). Clinical and ¹⁸F-FDG-PET/CT characteristics were compared between patients with clinically active and clinically inactive TA. Maximum SUV (SUV_max), mean SUV (SUV_mean), and SUV ratio (SUV_ratio) were significantly higher in the clinically active group than in the clinically inactive group (3.63 ± 1.96 vs. 1.82 ± 0.43, p = 0.007; 2.07 ± 0.71 vs. 1.43 ± 0.32, p = 0.009; 2.08 ± 1.17 vs. 0.95 ± 0.19, p = 0.000). Analyses of receiver operating characteristic (ROC) curves revealed a cutoff value of SUV_max of 2.21, with sensitivity and specificity of 86.2 and 90.0%, respectively, for clinically active TA. The SUV_ratio cutoff was 1.27 with a sensitivity and specificity of 79.3 and 100.0%, respectively. SUV_ratio was slightly superior to SUV_max and ARPs in the area under the curve (AUC) comparison. SUV_max and SUV_ratio showed a significant increasing trend with increasing US National Institutes of Health (NIH) score and levels of ARPs, interleukin-6, and serum amyloid-A protein. ¹⁸F-FDG-PET/CT is a promising non-invasive, quantitative measurement with high sensitivity and specificity for determining TA activity.

Available only for authorised users

Bicakcigil M, Aksu K, Kamali S, Ozbalkan Z, Ates A, Karadag O, Ozer HT, Seyahi E, Akar S, Onen F, Cefle A, Aydin SZ, Yilmaz N, Onat AM, Cobankara V, Tunc E, Ozturk MA, Fresko I, Karaaslan Y, Akkoc N, Yucel AE, Kiraz S, Keser G, Inanc M, Direskeneli H (2009) Takayasu’s arteritis in Turkey—clinical and angiographic features of 248 patients. Clin Exp Rheumatol 27(1 Suppl 52):S59–S64PubMed

Mason JC (2010) Takayasu arteritis—advances in diagnosis and management. Nat Rev Rheumatol 6(7):406–415. https://doi.org/10.1038/nrrheum.2010.82 CrossRefPubMed

Alibaz-Oner F, Aydin SZ, Direskeneli H (2013) Advances in the diagnosis, assessment and outcome of Takayasu’s arteritis. Clin Rheumatol 32(5):541–546. https://doi.org/10.1007/s10067-012-2149-3 CrossRefPubMed

Basu N, Watts R, Bajema I, Baslund B, Bley T, Boers M, Brogan P, Calabrese L, Cid MC, Cohen-Tervaert JW, Flores-Suarez LF, Fujimoto S, de Groot K, Guillevin L, Hatemi G, Hauser T, Jayne D, Jennette C, Kallenberg CG, Kobayashi S, Little MA, Mahr A, McLaren J, Merkel PA, Ozen S, Puechal X, Rasmussen N, Salama A, Salvarani C, Savage C, Scott DG, Segelmark M, Specks U, Sunderkoetter C, Suzuki K, Tesar V, Wiik A, Yazici H, Luqmani R (2010) EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis 69(10):1744–1750. https://doi.org/10.1136/ard.2009.119032 CrossRefPubMed

Yadav MK (2007) Takayasu arteritis: clinical and CT-angiography profile of 25 patients and a brief review of literature. Indian Heart J 59(6):468–474PubMed

Jiang L, Li D, Yan F, Dai X, Li Y, Ma L (2012) Evaluation of Takayasu arteritis activity by delayed contrast-enhanced magnetic resonance imaging. Int J Cardiol 155(2):262–267. https://doi.org/10.1016/j.ijcard.2010.10.002 CrossRefPubMed

Germano G, Monti S, Ponte C, Possemato N, Caporali R, Salvarani C, Macchioni P, Pipitone N (2017) The role of ultrasound in the diagnosis and follow-up of large-vessel vasculitis: an update. Clin Exp Rheumatol 103(1):194–198

Cavo M, Terpos E, Nanni C, Moreau P, Lentzsch S, Zweegman S, Hillengass J, Engelhardt M, Usmani SZ, Vesole DH, San-Miguel J, Kumar SK, Richardson PG, Mikhael JR, da Costa FL, Dimopoulos MA, Zingaretti C, Abildgaard N, Goldschmidt H, Orlowski RZ, Chng WJ, Einsele H, Lonial S, Barlogie B, Anderson KC, Rajkumar SV, Durie BGM, Zamagni E (2017) Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol 18(4):e206–e217. https://doi.org/10.1016/S1470-2045(17)30189-4 CrossRefPubMed

Gallamini A, Borra A (2017) FDG-PET scan: a new paradigm for follicular lymphoma management. Mediterranean J Hematol Infect Dis 9(1):e2017029. https://doi.org/10.4084/MJHID.2017.029 CrossRef

10.

Harrison DJ, Parisi MT, Shulkin BL (2017) The role of 18F-FDG-PET/CT in pediatric sarcoma. Semin Nucl Med 47(3):229–241. https://doi.org/10.1053/j.semnuclmed.2016.12.004 CrossRefPubMed

11.

Ishimori T, Saga T, Mamede M, Kobayashi H, Higashi T, Nakamoto Y, Sato N, Konishi J (2002) Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med : Off Publ Soc Nucl Med 43(5):658–663

12.

Kobayashi Y, Ishii K, Oda K, Nariai T, Tanaka Y, Ishiwata K, Numano F (2005) Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med : Off Publ Soc Nucl Med 46(6):917–922

13.

Tezuka D, Haraguchi G, Ishihara T, Ohigashi H, Inagaki H, Suzuki J, Hirao K, Isobe M (2012) Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging 5(4):422–429. https://doi.org/10.1016/j.jcmg.2012.01.013 CrossRefPubMed

14.

Arnaud L, Haroche J, Malek Z, Archambaud F, Gambotti L, Grimon G, Kas A, Costedoat-Chalumeau N, Cacoub P, Toledano D, Cluzel P, Piette JC, Amoura Z (2009) Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? Arthritis Rheum 60(4):1193–1200. https://doi.org/10.1002/art.24416 CrossRefPubMed

15.

Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129–1134CrossRefPubMed

16.

Li D, Lin J, Yan F (2011) Detecting disease extent and activity of Takayasu arteritis using whole-body magnetic resonance angiography and vessel wall imaging as a 1-stop solution. J Comput Assist Tomogr 35(4):468–474. https://doi.org/10.1097/RCT.0b013e318222d698 CrossRefPubMed

17.

Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120(11):919–929. https://doi.org/10.7326/0003-4819-120-11-199406010-00004 CrossRefPubMed

18.

Zhou J, Li Y, Zhang Y, Liu G, Tan H, Hu Y, Xiao J, Shi H (2017) Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma. Oncotarget 8(14):23312–23321. https://doi.org/10.18632/oncotarget.15577 CrossRefPubMedPubMedCentral

19.

Andrews J, Al-Nahhas A, Pennell DJ, Hossain MS, Davies KA, Haskard DO, Mason JC (2004) Non-invasive imaging in the diagnosis and management of Takayasu’s arteritis. Ann Rheum Dis 63(8):995–1000. https://doi.org/10.1136/ard.2003.015701 CrossRefPubMedPubMedCentral

20.

de Leeuw K, Bijl M, Jager PL (2004) Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides. Clin Exp Rheumatol 22(6 Suppl 36):S21–S26PubMed

21.

Webb M, Chambers A, AL-N A, Mason JC, Maudlin L, Rahman L, Frank J (2004) The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 31(5):627–634. https://doi.org/10.1007/s00259-003-1429-1 CrossRefPubMed

22.

Misra R, Danda D, Rajappa SM, Ghosh A, Gupta R, Mahendranath KM, Jeyaseelan L, Lawrence A, Bacon PA, Indian Rheumatology Vasculitis g (2013) Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology 52(10):1795–1801. https://doi.org/10.1093/rheumatology/ket128 CrossRefPubMed

23.

Hoffman GS, Ahmed AE (1998) Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol 66(Suppl 1):S191–S194 discussion S195CrossRefPubMed

24.

Ertay T, Sencan Eren M, Karaman M, Oktay G, Durak H (2017) 18F-FDG-PET/CT in initiation and progression of inflammation and infection. Mol Imaging and Radionuclide Ther 26(2):47–52. https://doi.org/10.4274/mirt.18291 CrossRef

25.

Walter MA, Melzer RA, Schindler C, Muller-Brand J, Tyndall A, Nitzsche EU (2005) The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 32(6):674–681. https://doi.org/10.1007/s00259-004-1757-9 CrossRefPubMed

26.

Henes JC, Muller M, Krieger J, Balletshofer B, Pfannenberg AC, Kanz L, Kotter I (2008) [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis. Clin Exp Rheumatol 26(3 Suppl 49):S47–S52PubMed

27.

Lee SG, Ryu JS, Kim HO, JS O, Kim YG, Lee CK, Yoo B (2009) Evaluation of disease activity using F-18 FDG PET-CT in patients with Takayasu arteritis. Clin Nucl Med 34(11):749–752. https://doi.org/10.1097/RLU.0b013e3181b7db09 CrossRefPubMed

28.

Lee KH, Cho A, Choi YJ, Lee SW, Ha YJ, Jung SJ, Park MC, Lee JD, Lee SK, Park YB (2012) The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with takayasu arteritis. Arthritis Rheum 64(3):866–875. https://doi.org/10.1002/art.33413 CrossRefPubMed

29.

Karapolat I, Kalfa M, Keser G, Yalcin M, Inal V, Kumanlioglu K, Pirildar T, Aksu K (2013) Comparison of F18-FDG PET/CT findings with current clinical disease status in patients with Takayasu’s arteritis. Clin Exp Rheumatol 31(1 Suppl 75):S15–S21PubMed

30.

Santhosh S, Mittal BR, Gayana S, Bhattacharya A, Sharma A, Jain S (2014) F-18 FDG PET/CT in the evaluation of Takayasu arteritis: an experience from the tropics. J Nucl Cardiol : Off Publ Am Soc Nucl Cardiol 21(5):993–1000. https://doi.org/10.1007/s12350-014-9910-8 CrossRef

31.

Sun Y, Ma L, Yan F, Liu H, Ding Y, Hou J, Jiang L (2012) MMP-9 and IL-6 are potential biomarkers for disease activity in Takayasu’s arteritis. Int J Cardiol 156(2):236–238. https://doi.org/10.1016/j.ijcard.2012.01.035 CrossRefPubMed

32.

Kong X, Sun Y, Ma L, Chen H, Wei L, Wu W, Ji Z, Ma L, Zhang Z, Zhang Z, Zhao Z, Hou J, Dai S, Yang C, Jiang L (2016) The critical role of IL-6 in the pathogenesis of Takayasu arteritis. Clin Exp Rheumatol 34(3 Suppl 97):S21–S27PubMed

Title: 18F-FDG-PET/CT: an accurate method to assess the activity of Takayasu’s arteritis
Authors: Xiaojie Zhang
Jun Zhou
Ying Sun
Hongcheng Shi
Zongfei Ji
Lindi Jiang
Publication date: 01-07-2018
Publisher: Springer London
Published in: Clinical Rheumatology / Issue 7/2018
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-017-3960-7

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

¹⁸F-FDG-PET/CT: an accurate method to assess the activity of Takayasu’s arteritis

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2018

Clinical characteristics of conduction disturbance in patients with Behcet’s disease

Gouty arthritis: decision-making following dual-energy CT scan in clinical practice, a retrospective analysis

Influence of the different “patient global assessment” formulations on disease activity score by different indices in rheumatoid arthritis

Genetic polymorphism of rs9277535 in HLA-DP associated with rheumatoid arthritis and anti-CCP production in a Chinese population

C-reactive protein (CRP) polymorphisms and haplotypes are associated with SLE susceptibility and activity but not with serum CRP levels in Mexican population

The outcomes and risk factors of early readmission in patients with intestinal Behçet’s disease

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page